Thus, enhanced Fas-FasL activity as well as upregulated activity of other apoptosis-promoting molecules in IL-2-deficient erythroid cells results in increased cell death leading to anemia development in Il2−/− mice. The gene discussed is FASLG; the disease is anemia.